Virtu Financial’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.17M	Buy	+38,479	New	+$2.24M	0.09%	143
2024 Q4	–	Sell	-11,504	Closed	-$809K	–	1567
2024 Q3	$809K	Buy	+11,504	New	+$962K	0.04%	309
2022 Q4	–	Sell	-10,575	Closed	-$896K	–	1635
2022 Q3	$896K	Buy	+10,575	New	+$942K	0.08%	220
2022 Q2	–	Sell	-12,122	Closed	-$935K	–	1602
2022 Q1	$935K	Buy	+12,122	New	+$1.01M	0.07%	230
2021 Q4	–	Sell	-3,700	Closed	-$286K	–	1724
2021 Q3	$286K	Buy	+3,700	New	+$292K	0.03%	738
2020 Q4	–	Sell	-18,026	Closed	-$1.37M	–	1449
2020 Q3	$1.37M	Buy	+18,026	New	+$1.82M	0.24%	85
2019 Q4	–	Sell	-7,759	Closed	-$523K	–	1451
2019 Q3	$523K	Buy	+7,759	New	+$598K	0.04%	495
2019 Q2	–	Sell	-14,015	Closed	-$1.25M	–	1472
2019 Q1	$1.25M	Buy	14,015 +10,029	+252%	+$930K	0.09%	251
2018 Q4	$339K	Sell	3,986 -3,308	-45%	-$315K	0.03%	660
2018 Q3	$707K	Buy	+7,294	New	+$728K	0.05%	450
2018 Q1	–	Sell	-3,019	Closed	-$269K	–	1973
2017 Q4	$269K	Sell	3,019 -1,146	-28%	-$99.6K	0.01%	1360
2017 Q3	$388K	Buy	+4,165	New	+$368K	0.02%	1136
2016 Q4	–	Sell	-3,171	Closed	-$293K	–	448
2016 Q3	$293K	Buy	+3,171	New	+$299K	0.05%	276
2016 Q1	–	Sell	-2,994	Closed	-$314K	–	402
2015 Q4	$314K	Buy	+2,994	New	+$313K	0.04%	287
2015 Q3	–	Sell	-5,220	Closed	-$714K	–	320
2015 Q2	$714K	Buy	+5,220	New	+$647K	0.06%	172
2014 Q4	–	Sell	-3,668	Closed	-$265K	–	308
2014 Q3	$265K	Buy	+3,668	New	+$241K	0.03%	239